Phase Ib/II study of pembrolizumab and pegylated-interferon alfa-2b in advanced melanoma

Diwakar Davar, Hong Wang, Joe Marc Chauvin, Ornella Pagliano, Julien J. Fourcade, Mignane Ka, Carmine Menna, Amy Rose, Cindy Sander, Amir A. Borhani, Arivarasan Karunamurthy, Ahmad A. Tarhini, Hussein A. Tawbi, Qing Zhao, Blanca H. Moreno, Scott Ebbinghaus, Nageatte Ibrahim, John M. Kirkwood, Hassane M. Zarour^*